Estrella Immunopharma(ESLA) - 2023 Q1 - Quarterly Report

Or UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 (Registrant's telephone number, including area code) (Former name, former address and former fiscal year, if changed since last report) Commission File Number: 001-40608 TradeUP Acquisition Corp. (Exact name of registrant as specified in its charter) | Delaware | 85-1314502 | | ...